Extranodal NK-/T-Cell Lymphoma, Nasal Type

Extranodal NK-/T-Cell Lymphoma, Nasal Type — Trials · CancerIndex

Clinical trials

Registered studies

23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Dren Bio
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04509466	Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL	terminated	Phase 1 / Phase 2	41	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY	1	Mar 7, 2024	clinicaltrials
NCT04602065	Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial	terminated	Phase 1 / Phase 2	9	Innovent Biologics (Suzhou) Co. Ltd.INDUSTRY	1	Mar 15, 2023